3-(1-BENZYL-1,2,3,6-TETRAHYDRO-4-PYRIDINYL)-1H-INDOLE-5-CARBONITRILE, 97.0%, 250mg

4-Amino-benzoic acid 2-methoxy-ethyl esteroxalic acid salt, 1g

Ethyl 2-(((benzyloxy)carbonyl)amino)acetate, 95.0%, 100g

4-(4-Hydroxy-3-methoxyphenyl)butan-2-one, 95.0%, 10g

L-lysine monohydrate, min. 98.5%, for biochemistry, 25 g, plastic packaging.

Ethyl 6-bromo-3-chloro-5-methylpyrazine-2-carboxylate, 95%, 100mg

6-(2-aminoethyl)-2(1H)-pyridinone dihydrochloride, 95.0%, 1g

(S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethan-1-amine hydrochloride, 97%, 100mg

2-(6-Bromo-1H-indol-3-yl)acetonitrile, 97%, 10g

N,N-Dimethyl-1H-pyrazole-1-sulfonamide, 95.0%, 250mg

(S)-2-(3-Chlorophenyl)pyrrolidine hydrochloride, 95.0%, 1g

6-Methoxy-2-(4-phenoxybenzoyl)pyridine, 97.0%, 1g

Naphtho[2,3-a]pyrene, >98.0%(GC), 25mg